{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-22-175515","form_type":"8-K","ticker":"ALXO","cik":"0001810182","company_name":"ALX ONCOLOGY HOLDINGS INC","filed_at":"2022-06-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:02.418442+00:00","generated_at":"2026-06-25T01:22:13.059589+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"ALX Oncology annual meeting results: two directors re-elected, Say-on-Pay approved, KPMG ratified","bullets":["Itziar Canamasas and Jack Nielsen reelected as Class II directors with 31,224,326 and 27,509,300 votes for respectively.","Advisory Say-on-Pay proposal approved (28,566,208 for, 3,738,258 against, 8,032 abstain).","Stockholders selected every year for frequency of future Say-on-Pay votes (32,294,203 votes for every year).","Ratification of KPMG LLP as independent auditor for fiscal 2022 approved (34,268,632 for, 643 against, 1,668 abstain)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-22-175515","json":"https://secwatch.observer/filing/0001193125-22-175515.json","markdown":"https://secwatch.observer/filing/0001193125-22-175515.md","text":"https://secwatch.observer/filing/0001193125-22-175515.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1810182/000119312522175515/0001193125-22-175515-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1810182/000119312522175515/d350279d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T01:22:13.059589+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}